|
2. Goodlad JR and Fletcher CD: Solitary fibrous tumors arising at
unusual sites: Analysis of a series Histopathology. 19:515–522. 1991.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
3 Lin Q, Zhu J and Zhang X:Solitary fibrous tumor of the central nervous
system invading and penetrating the skull: a case report. January
10,2023. View article: https://doi.org/10.3892/ol.2023.13667
4. Thway K, Ng W, Noujaim J, Jones RL, and Fisher C: The current status
of solitary fibrous tumors: diagnostic features, variants, and genetics.
Int J Surg Pathol. 24:281–292. 2016.
View Article:
Google
Scholar: PubMed/NCBI
|
|
5. Zeng L, Wang Y, Wang Y, Han L, Niu H, Zhang M, Ke C, Chen J, and
Lei T: Analyses of prognosis-related factors of intracranial solitary
fibrous tumors and hemangiopericytomas help understand the relationship
between the two sorts of tumors. J Neurooncol. 131:153–161. 2017.
View Article:
Google
Scholar: PubMed/NCBI
|
|
6. Zhang DY, Su L, and Wang YW: Malignant solitary fibrous tumor in
the central nervous system treated with surgery, radiotherapy, and
anlotinib: A case report. World J Clin Cases. 10:631–642. 2022.
View Article:
Google
Scholar: PubMed/NCBI
|
|
7. Louis DN, Perry A, Reifenberger G, von Deimling A,
Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, and
Ellison DW: The 2016 World Health Organization classification of tumors
of the central nervous system: A summary. Acta Neuropathol.
131:803–820. 2016.
View Article:
Google
Scholar: PubMed/NCBI
|
|
8. Wang XQ, Zhou Q, Li ST, Liao CL, Zhang H, and Zhang BY: Solitary
fibrous tumors of the central nervous system: clinical features and
imaging findings in 22 patients. J Comput Assist Tomogr. 37:658–665.
2013. View
Article:
Google
Scholar: PubMed/NCBI
|
|
9. Sugiyama H, Tsutsumi S, Hashizume A, Inaba T, and Ishii H: Are
bone erosion and peripheral feeding vessels hallmarks of intracranial
solitary fibrous tumor/hemangiopericytoma? Radiol Case Rep.
17:2702–2707. 2022.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
10. Peng Z, Wang Y, Wang Y, Li Q, Fang Y, Fan R, Zhang H, and Jiang
W: Hemangiopericytoma/solitary fibrous tumor of the cranial base: A case
series and literature review. BMC Surg. 22:2892022.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
11. Bai LC, Luo TY, Zhu H, and Xu R: MRI features of intracranial
anaplastic hemangiopericytoma. Oncol Lett. 13:2945–2948, 2017.
View Article:
Google
Scholar: PubMed/NCBI
|
|
12. Chen T, Jiang B, Zheng Y, She D, Zhang H, Xing Z, and Cao D:
Differentiating intracranial solitary fibrous tumor/hemangiopericytoma
from meningioma using diffusion-weighted imaging and
susceptibility-weighted imaging. Neuroradiology, 62:175–184, 2020.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
13. Sun LJ, Dong J, Gao F, Chen DM, Li K, Liu J, Zhang C, Tohti M,
and Yang XP: Intracranial solitary fibrous tumor: Report of two cases.
Medicine (Baltimore). 98:e153272019.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
14. Lee JH, Jeon SH, Park CK, Park SH, Yoon HI, Chang JH, Suh CO,
Kang SJ, Lim DH, Kim IA, et al.: The role of postoperative radiotherapy
in intracranial solitary fibrous tumor/hemangiopericytoma: A
multi-institutional retrospective study (KROG 18–11). Cancer Res Treat.
54:65–74, 2022.
View Article:
Google
Scholar: PubMed/NCBI
|
|
15. Yu Y, Hu Y, Lv L, Chen C, Yin S, Jiang S, and Zhou P: Clinical
outcomes in central nervous system solitary-fibrous
tumor/hemangiopericytoma: A STROBE-compliant single-center analysis.
World J Surg Oncol. 20:1492022.
View
Article:
Google
Scholar: PubMed/NCBI
|
|
16. Schutz FA, Choueiri TK, and Sternberg CN: Pazopanib: Clinical
Development of a Potent Anti-Angiogenic Drug Crit Rev Oncol Hematol.
77:163–171. 2011.
View
Article:
Google
Scholar: PubMed/NCBI
17. Martin-Broto J, Cruz J, Penel N, Le Cesne A, Hindi N, Luna P, Moura
DS, Bernabeu D, de Alava E, Lopez-Guerrero JA, et al. Pazopanib for
treatment of typical solitary fibrous tumors: A multicentre, single-arm,
phase 2 trial Lancet Oncol. 21:456–466. 2020.
View
Article:
Google
Scholar: PubMed/NCBI
|